Nov 21, 2019· Comment from Association for Accessible Medicines (AAM)· FDA-2019-N-3403-0015
Comments from The Association for Accessible Medicines (AAM) on behalf of our member companies regarding FDA-2019-N-3403: Solicits Input on Potential Role for Abuse-Deterrent Formulations of Central Nervous System Stimulants.